把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注，缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存；每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR，A 股链接巨潮原始 PDF，港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性，不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查；超出容差的记录保留原值并标记警告， 不会为了让公式“对上”而修改公司披露。
| 2026-06-30 |
| 3/3 |
| $164.2M |
| -$1.16B |
| -$723.3M |
| 42.7% |
| -47.8% |
| 177 |
| 尚无授权文本 |
| GATX GATX CORP | 2026-06-30 | 3/3 | $580.1M | $103.4M | — | — | — | 102 | 尚无授权文本 |
| RTX RTX Corp | 2026-06-30 | 3/3 | $24.71B | $2.14B | $4.19B | — | 11.4% | 92 | 尚无授权文本 |
| TCBI TEXAS CAPITAL BANCSHARES INC/TX | 2026-06-30 | 3/3 | — | $84.95M | $179.67M | — | — | 77 | 尚无授权文本 |
| TCBIO TEXAS CAPITAL BANCSHARES INC/TX | 2026-06-30 | 3/3 | — | $84.95M | $179.67M | — | — | 77 | 尚无授权文本 |
| TXN TEXAS INSTRUMENTS INC | 2026-06-30 | 3/3 | $5.46B | $1.98B | $3.03B | 61.4% | 42.3% | 81 | 尚无授权文本 |
| VKTX Viking Therapeutics, Inc. | 2026-06-30 | 3/3 | $0 | -$128.02M | — | — | — | 70 | 尚无授权文本 |
| VLO VALERO ENERGY CORP/TX | 2026-06-30 | 3/3 | — | $3.72B | — | — | — | 86 | 尚无授权文本 |
| BCTX BriaCell Therapeutics Corp. | 2026-04-30 | 3/3 | — | -$7.16M | -$22.82M | — | — | 133 | 尚无授权文本 |
| STX Seagate Technology Holdings plc | 2026-04-03 | 3/3 | $3.11B | $748M | $1.99B | 46.5% | 32.1% | 108 | 尚无授权文本 |
| AKTX Akari Therapeutics Plc | 2026-03-31 | 3/3 | — | -$14.46M | — | — | — | 135 | 尚无授权文本 |
| AMTX AEMETIS, INC | 2026-03-31 | 3/3 | — | -$21.71M | -$17.11M | — | — | 93 | 尚无授权文本 |
| ANTX AN2 Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$10.03M | — | — | — | 56 | 尚无授权文本 |
| ATXG ADDENTAX GROUP CORP. | 2026-03-31 | 3/3 | $5.37M | -$4.47M | -$784,497 | 14.1% | -28.5% | 84 | 尚无授权文本 |
| AVTX Avalo Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$19.63M | — | — | — | 141 | 尚无授权文本 |
| BDTX Black Diamond Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$9.04M | — | — | — | 81 | 尚无授权文本 |
| BRTX BioRestorative Therapies, Inc. | 2026-03-31 | 3/3 | $23,170 | -$2.15M | — | 68.1% | -14612.6% | 74 | 尚无授权文本 |
| CATX Perspective Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$26.19M | -$38.33M | — | — | 152 | 尚无授权文本 |
| CETX CEMTREX INC | 2026-03-31 | 3/3 | $18.06M | $907,048 | -$5.65M | 37.9% | -12.0% | 110 | 尚无授权文本 |
| CGTX COGNITION THERAPEUTICS INC | 2026-03-31 | 3/3 | — | -$4.57M | — | — | — | 89 | 尚无授权文本 |
| CNTX Context Therapeutics Inc. | 2026-03-31 | 3/3 | — | -$8.68M | -$11.47M | — | — | 71 | 尚无授权文本 |
| CTXR Citius Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | $1.67M | -$28.11M | — | 80.3% | -1931.0% | 137 | 尚无授权文本 |
| DFTX Definium Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$77.1M | — | — | — | 138 | 尚无授权文本 |
| DWTX Dogwood Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$4.99M | — | — | — | 93 | 尚无授权文本 |
| ELTX Elicio Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$11.82M | — | — | — | 99 | 尚无授权文本 |
| ENTX Entera Bio Ltd. | 2026-03-31 | 3/3 | $0 | -$3.51M | -$3.09M | — | — | 102 | 尚无授权文本 |
| EWTX Edgewise Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$49.01M | -$42.8M | — | — | 69 | 尚无授权文本 |
| FHTX Foghorn Therapeutics Inc. | 2026-03-31 | 3/3 | $3.27M | -$19.88M | -$25.27M | — | -660.3% | 110 | 尚无授权文本 |
| GNTX GENTEX CORP | 2026-03-31 | 3/3 | $675.44M | $98.46M | — | 33.8% | 18.3% | 59 | 尚无授权文本 |
| GTX Garrett Motion Inc. | 2026-03-31 | 3/3 | $985M | $95M | $69M | 19.9% | — | 119 | 尚无授权文本 |
| HRTX HERON THERAPEUTICS, INC. /DE/ | 2026-03-31 | 3/3 | — | -$8.11M | -$1.93M | — | — | 107 | 尚无授权文本 |
| IOR INCOME OPPORTUNITY REALTY INVESTORS INC /TX/ | 2026-03-31 | 3/3 | — | $1.01M | — | — | — | 62 | 尚无授权文本 |
| KYTX Kyverna Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$39.73M | — | — | — | 49 | 尚无授权文本 |
| LCTX Lineage Cell Therapeutics, Inc. | 2026-03-31 | 3/3 | $1.73M | -$4.81M | -$8.13M | — | -440.2% | 98 | 尚无授权文本 |
| MATX Matson, Inc. | 2026-03-31 | 3/3 | $757.8M | $56.6M | — | — | 8.1% | 101 | 尚无授权文本 |
| MGTX MeiraGTx Holdings plc | 2026-03-31 | 3/3 | $293,000 | -$46.31M | $15.8M | — | -13930.7% | 82 | 尚无授权文本 |
| MKTX MARKETAXESS HOLDINGS INC | 2026-03-31 | 3/3 | $233.38M | $77.88M | -$75.59M | — | 43.2% | 78 | 尚无授权文本 |
| MLTX MoonLake Immunotherapeutics | 2026-03-31 | 3/3 | — | -$69.71M | -$66.29M | — | — | 74 | 尚无授权文本 |
| MMTX Miluna Acquisition Corp | 2026-03-31 | 3/3 | — | $462,457 | — | — | — | 11 | 尚无授权文本 |
| NKTX Nkarta, Inc. | 2026-03-31 | 3/3 | — | -$27.83M | -$28.61M | — | — | 82 | 尚无授权文本 |
| NUTX Nutex Health Inc. | 2026-03-31 | 3/3 | $216.49M | $46.81M | $74.32M | 42.4% | 37.5% | 94 | 尚无授权文本 |
| ODTX Odyssey Therapeutics, Inc. | 2026-03-31 | 3/3 | $0 | -$38.26M | -$41.18M | — | — | 4 | 尚无授权文本 |
| OPTX SYNTEC OPTICS HOLDINGS, INC. | 2026-03-31 | 3/3 | $6.51M | -$897,857 | $175,286 | 14.8% | -11.9% | 56 | 尚无授权文本 |
| OSTX OS Therapies Inc | 2026-03-31 | 3/3 | — | -$10.4M | — | — | — | 42 | 尚无授权文本 |
| RNTX Rein Therapeutics, Inc. | 2026-03-31 | 3/3 | $0 | -$5.84M | — | — | — | 87 | 尚无授权文本 |
| RUSHA RUSH ENTERPRISES INC \TX\ | 2026-03-31 | 3/3 | $1.59B | $61.45M | -$5.63M | 21.6% | 5.2% | 112 | 尚无授权文本 |
| RUSHB RUSH ENTERPRISES INC \TX\ | 2026-03-31 | 3/3 | $1.59B | $61.45M | -$5.63M | 21.6% | 5.2% | 112 | 尚无授权文本 |
| SINT Sintx Technologies, Inc. | 2026-03-31 | 3/3 | $380,000 | -$2.82M | -$2.5M | 37.9% | -843.9% | 97 | 尚无授权文本 |
| SPTX Seaport Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$25.41M | -$20.17M | — | — | 3 | 尚无授权文本 |
| STXS Stereotaxis, Inc. | 2026-03-31 | 3/3 | $6.29M | -$5.86M | — | 60.3% | -95.1% | 68 | 尚无授权文本 |
| TGTX TG THERAPEUTICS, INC. | 2026-03-31 | 3/3 | $204.92M | $19.78M | -$17.95M | 83.6% | 17.0% | 73 | 尚无授权文本 |
| TRTX TPG RE Finance Trust, Inc. | 2026-03-31 | 3/3 | — | $18.94M | — | — | — | 89 | 尚无授权文本 |
| TVTX Travere Therapeutics, Inc. | 2026-03-31 | 3/3 | $127.2M | -$37.1M | — | 98.5% | -29.0% | 108 | 尚无授权文本 |
| TXG 10x Genomics, Inc. | 2026-03-31 | 3/3 | $150.84M | -$13.47M | $24.52M | 70.4% | -11.3% | 71 | 尚无授权文本 |
| TXMD TherapeuticsMD, Inc. | 2026-03-31 | 3/3 | $724,000 | $95,000 | — | — | -99.9% | 100 | 尚无授权文本 |
| TXNM TXNM ENERGY INC | 2026-03-31 | 3/3 | $487.79M | $8.01M | — | — | 15.8% | 142 | 尚无授权文本 |
| TXO TXO Partners, L.P. | 2026-03-31 | 3/3 | $119.56M | -$74.34M | — | — | -64.9% | 45 | 尚无授权文本 |
| TXRH Texas Roadhouse, Inc. | 2026-03-31 | 3/3 | $1.63B | $126M | $178.92M | — | 9.0% | 92 | 尚无授权文本 |
| VHC VirnetX Holding Corp | 2026-03-31 | 3/3 | $0 | -$4.35M | — | — | — | 45 | 尚无授权文本 |
| VOYG Voyager Technologies, Inc./TX | 2026-03-31 | 3/3 | $35.25M | -$43.98M | -$90.83M | -4.4% | -126.7% | 16 | 尚无授权文本 |
| VRTX VERTEX PHARMACEUTICALS INC / MA | 2026-03-31 | 3/3 | $2.99B | $1.03B | $1.29B | 86.8% | 38.1% | 72 | 尚无授权文本 |
| BNTX BioNTech SE | 2025-12-31 | 2/3 | — | -$1.14B | — | — | — | 324 | 尚无授权文本 |
| IMTX Immatics N.V. | 2025-12-31 | 2/3 | — | -$196.45M | — | — | — | 96 | 尚无授权文本 |
| NBTX Nanobiotix S.A. | 2025-12-31 | 2/3 | — | -$23.96M | — | — | — | 230 | 尚无授权文本 |
| TX Ternium S.A. | 2025-12-31 | 2/3 | — | $303.1M | — | — | — | 118 | 尚无授权文本 |
| XRTX XORTX Therapeutics Inc. | 2021-12-31 | 2/3 | — | -$1.65M | — | — | — | 176 | 尚无授权文本 |
| BTX BlackRock Technology & Private Equity Term Trust | — | 0/3 | — | — | — | — | — | 0 | 尚无授权文本 |
| DETX LIBERTY DEFENSE HOLDINGS, LTD. | — | 0/3 | — | — | — | — | — | 6 | 尚无授权文本 |
| ETX Eaton Vance Municipal Income 2028 Term Trust | — | 0/3 | — | — | — | — | — | 9 | 尚无授权文本 |
| MTR MESA ROYALTY TRUST/TX | — | 0/3 | — | — | — | — | — | 96 | 尚无授权文本 |